Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib Continuous Dosing in Advanced GIST
NCT00137449Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2005
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of sunitinib in gastrointestinal stromal tumor (GIST), sponsored by Pfizer. Started Sep 2005; status: completed.
02
Drugs
sunitinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00137449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00137449.